Market Research Logo

In-Vitro Diagnostics Market Global Report 2017 Including: Point-Of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology And ImmunohematologyCovering: F. Hoffmann-La Roche Ltd, Siemens Healthine

In-Vitro Diagnostics Market Global Report 2017 Including: Point-Of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology And ImmunohematologyCovering: F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc., and Thermo Fisher Scientific

In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids.

The In-Vitro Diagnostics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global in-vitro diagnostics market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the In-vitro diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The In-vitro diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider medical equipment market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The In-vitro diagnostics market section of the report gives context. It compares the In-vitro diagnostics market with other segments of the medical equipment market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The In-Vitro Diagnostics Indicators Comparison.
  • The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope

Markets Covered: Point-Of-Care Diagnostics, Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hemostasis, Hematology And Immunohematology

Companies Mentioned: F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc., and Thermo Fisher Scientific

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The In-Vitro Diagnostics Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. In-Vitro Diagnostics Market Characteristics
2. In-Vitro Diagnostics Market Size And Growth
2.1. Historic Market Growth
2.1.1. Drivers Of The Market
2.1.2. Restraints On The Market
2.2. Forecast Market Growth
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market
3. Pestle Analysis
3.1. Political
3.2. Economic
3.3. Social
3.4. Technological
3.5. Legal
3.6. Environmental
4. In-Vitro Diagnostics Market Customer Information
5. In-Vitro Diagnostics Market Segmentation
5.1. Global In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
5.2. Global In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Segment
5.3 Global In-Vitro Diagnostics Market Trends And Strategies
Strategic Collaborations And Agreements
New Product Launches
Rising Demand for Point-of-Care (POC) Testing
5.4 Global In-Vitro Diagnostics Market Compared With Similar Markets, 2016
5.5 Global In-Vitro Diagnostics Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast
5.6 In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Region
5.7. In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Country
5.8 Point-Of-Care Diagnostics
5.8.1 Market Characteristics
5.8.2. Global Point-Of-Care Diagnostics Market, 2016, By Segment
5.8.3. Market Trends And Strategies
5.9 Immunochemistry
5.9.1. Market Characteristics
5.9.2. Global Immunochemistry Market, 2016, By Segment
5.9.3. Market Trends And Strategies
5.10 Clinical Chemistry
5.10.1. Market Characteristics
5.10.2. Global Clinical Chemistry Market, 2016, By Segment
5.10.3. Market Trends And Strategies
5.11 Molecular Diagnostics
5.11.1. Market Characteristics
5.11.2. Global Molecular Diagnostics Market, 2016, By Segment
5.11.3. Market Trends And Strategies
5.12 Microbiology
5.12.1. Market Characteristics
5.12.2. Global Microbiology Market, 2016, By Segment
5.12.3. Market Trends And Strategies
5.13 Hemostasis
5.13.1. Market Characteristics
5.13.2. Global Hemostasis Market, 2016, By Segment
5.13.3. Market Trends And Strategies
5.14 Hematology And Immunohematology
5.14.1. Market Characteristics
5.14.2. Global Hematology And Immunohematology Market, 2016, By Segment
5.14.3. Market Trends And Strategies
6. In-Vitro Diagnostics Market Regional And Country Analysis
6.1. Global In-Vitro Diagnostics Market, 2016, By Region
6.2. Global In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Region
6.3. In-Vitro Diagnostics Market, 2016, By Country
6.4. In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Country
6.5. Global Healthcare Market Segments, 2016, By Region
6.6. Global Medical Equipment Market Segments, 2016, By Region
6.7. Global Healthcare Market Segments, 2016, By Country
6.8. Global Medical Equipment Market Segments, 2016, By Country
7. Global In-Vitro Diagnostics Market Comparison With Macro Economic Factors
7.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, Global
7.2. Per Capita Average In-Vitro Diagnostics Expenditure, Global
8. In-Vitro Diagnostics Market Comparison With Macro Economic Factors Across Countries
8.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, By Country
8.2. Per Capita Average In-Vitro Diagnostics Expenditure, By Country
9. In-Vitro Diagnostics Market Comparison With Industry Metrics
9.1. Global Number Of Medical Labs, 2016, By Country
9.2. Global In-Vitro Diagnostics Market Revenue Versus Number Of Medical Labs, 2016, By Country
10. Asia-Pacific In-Vitro Diagnostics Market
10.1.1. Asia-Pacific In-Vitro Diagnostics Market Overview
10.1.2. Asia-Pacific In-Vitro Diagnostics Historic Market, 2012 - 2016
10.1.3. Asia-Pacific In-Vitro Diagnostics Forecast Market, 2016 - 2020
10.1.4. Asia-Pacific In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
10.2. Asia-Pacific In-Vitro Diagnostics Market: Country Analysis
10.3. China In-Vitro Diagnostics Market
10.3.1. China In-Vitro Diagnostics Market Overview
10.3.2. China In-Vitro Diagnostics Historic Market, 2012 - 2016
10.3.3. China In-Vitro Diagnostics Forecast Market, 2016 - 2020
10.3.4. China In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
10.3.5. China In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
10.3.6. China Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
10.4. India In-Vitro Diagnostics Market
10.4.1. India In-Vitro Diagnostics Market Overview
10.4.2. India In-Vitro Diagnostics Historic Market, 2012 - 2016
10.4.3. India In-Vitro Diagnostics Forecast Market, 2016 - 2020
10.4.4. India In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
10.4.5. India In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
10.4.6. India Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
10.5. Japan In-Vitro Diagnostics Market
10.5.1. Japan In-Vitro Diagnostics Market Overview
10.5.2. Japan In-Vitro Diagnostics Historic Market, 2012 - 2016
10.5.3. Japan In-Vitro Diagnostics Forecast Market, 2016 - 2020
10.5.4. Japan In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
10.5.5. Japan In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
10.5.6. Japan Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
10.6. Australia In-Vitro Diagnostics Market
10.6.1. Australia In-Vitro Diagnostics Historic Market, 2012 - 2016
10.6.2. Australia In-Vitro Diagnostics Forecast Market, 2016 - 2020
10.6.3. Australia In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
10.6.4. Australia In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
10.6.5. Australia Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
11. Western Europe In-Vitro Diagnostics Market
11.1.1. Western Europe In-Vitro Diagnostics Market Overview
11.1.2. Western Europe In-Vitro Diagnostics Historic Market, 2012 - 2016
11.1.3. Western Europe In-Vitro Diagnostics Forecast Market, 2016 - 2020
11.1.4. Western Europe In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
11.2. Western Europe In-Vitro Diagnostics Market: Country Analysis
11.3. UK In-Vitro Diagnostics Market
11.3.1. UK In-Vitro Diagnostics Market Overview
11.3.2. UK In-Vitro Diagnostics Historic Market, 2012 - 2016
11.3.3. UK In-Vitro Diagnostics Forecast Market, 2016 - 2020
11.3.4. UK In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
11.3.5. UK In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
11.3.6. UK Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
11.4. Germany In-Vitro Diagnostics Market
11.4.1. Germany In-Vitro Diagnostics Historic Market, 2012 - 2016
11.4.2. Germany In-Vitro Diagnostics Forecast Market, 2016 - 2020
11.4.3. Germany In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
11.4.4 Germany In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
11.4.5 Germany Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
11.5 France In-Vitro Diagnostics Market
11.5.1 France In-Vitro Diagnostics Historic Market, 2012 - 2016
11.5.2 France In-Vitro Diagnostics Forecast Market, 2016 - 2020
11.5.3 France In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
11.5.4 France In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
11.5.5 France Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
11.6. Italy In-Vitro Diagnostics Market
11.6.1. Italy In-Vitro Diagnostics Historic Market, 2012 - 2016
11.6.2. Italy In-Vitro Diagnostics Forecast Market, 2016 - 2020
11.6.3. Italy In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
11.6.4. Italy In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
11.6.5. Italy Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
11.7. Spain In-Vitro Diagnostics Market
11.7.1. Spain In-Vitro Diagnostics Historic Market, 2012 - 2016
11.7.2. Spain In-Vitro Diagnostics Forecast Market, 2016 - 2020
11.7.3. Spain In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
11.7.4. Spain In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
11.7.5. Spain Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
12. Eastern Europe In-Vitro Diagnostics Market
12.1.1. Eastern Europe In-Vitro Diagnostics Market Overview
12.1.2. Eastern Europe In-Vitro Diagnostics Historic Market, 2012 - 2016
12.1.3. Eastern Europe In-Vitro Diagnostics Forecast Market, 2016 - 2020
12.1.4 Eastern Europe In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
12.2. Eastern Europe In-Vitro Diagnostics Market: Country Analysis
12.3. Russia In-Vitro Diagnostics Market
12.3.1. Russia In-Vitro Diagnostics Historic Market, 2012 - 2016
12.3.2. Russia In-Vitro Diagnostics Forecast Market, 2016 - 2020
12.3.3. Russia In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
12.3.4. Russia In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
12.3.5. Russia Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
13. North America In-Vitro Diagnostics Market
13.1.1. North America In-Vitro Diagnostics Market Overview
13.1.2. North America In-Vitro Diagnostics Historic Market, 2012 - 2016
13.1.3. North America In-Vitro Diagnostics Forecast Market, 2016 - 2020
13.1.4. North America In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
13.2. North America In-Vitro Diagnostics Market: Country Analysis
13.3. USA In-Vitro Diagnostics Market
13.3.1. USA In-Vitro Diagnostics Historic Market, 2012 - 2016
13.3.2. USA In-Vitro Diagnostics Forecast Market, 2016 - 2020
13.3.3 USA In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
13.3.4. USA In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
13.3.5. USA Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
14. South America In-Vitro Diagnostics Market
14.1.1. South America In-Vitro Diagnostics Market Overview
14.1.2. South America In-Vitro Diagnostics Historic Market, 2012 - 2016
14.1.3. South America In-Vitro Diagnostics Forecast Market, 2016 - 2020
14.1.4. South America In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
14.2. South America In-Vitro Diagnostics Market: Country Analysis
14.3. Brazil In-Vitro Diagnostics Market
14.3.1. Brazil In-Vitro Diagnostics Historic Market, 2012 - 2016
14.3.2. Brazil In-Vitro Diagnostics Forecast Market, 2016 - 2020
14.3.3. Brazil In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
14.3.4. Brazil In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020
14.3.5. Brazil Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020
15. Middle East In-Vitro Diagnostics Market
15.1.1. Middle East In-Vitro Diagnostics Market Overview
15.1.2. Middle East In-Vitro Diagnostics Historic Market, 2012 - 2016
15.1.3. Middle East In-Vitro Diagnostics Forecast Market, 2016 - 2020
15.1.4. Middle East In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
16. Africa In-Vitro Diagnostics Market
16.1.1. Africa In-Vitro Diagnostics Market Overview
16.1.2. Africa In-Vitro Diagnostics Historic Market, 2012 - 2016
16.1.3. Africa In-Vitro Diagnostics Forecast Market, 2016 - 2020
16.1.4. Africa In-Vitro Diagnostics Market, 2016, By Segment
Point-Of-Care Diagnostics
Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Microbiology
Hemostasis
Hematology And Immunohematology
17. In-Vitro Diagnostics Market Competitive Landscape
17.1. Company Profiles
17.2. F. Hoffmann-La Roche Ltd
17.2.1. Overview
17.2.2. Products And Services
17.2.3. Strategy
17.2.4. Financial Performance
17.3. Siemens Healthineers
17.3.1. Overview
17.3.2. Products And Services
17.3.3. Strategy
17.3.4. Financial Performance
17.4. Danaher (Beckman Coulter Inc)
17.4.1. Overview
17.4.2. Products And Services
17.4.3. Strategy
17.4.4. Financial Performance
17.5. Abbott Laboratories Inc.
17.5.1. Overview
17.5.2. Products And Services
17.5.3. Strategy
17.5.4. Financial Performance
17.6. Thermo Fisher Scientific
17.6.1. Overview
17.6.2. Products And Services
17.6.3. Strategy
17.6.4. Financial Performance
18. Key Mergers And Acquisitions In The In-Vitro Diagnostics Market
19. Market Background: Medical Equipment Market
19.1.1. Medical Equipment Market Characteristics
19.1.2. Medical Equipment Market Historic Growth
19.1.2.1. Drivers Of The Market
19.1.2.2. Restraints Of The Market
19.1.3. Medical Equipment Market Forecast Growth
19.1.3.1. Drivers Of The Market
19.1.3.2. Restraints Of The Market
19.1.4. Medical Equipment Trends And Strategies
19.2. Medical Equipment Market Regional And Country Analysis
19.2.1. Global Medical Equipment Market, 2016, By Region
19.2.2. Global Medical Equipment Market, 2012 - 2020, Historic And Forecast, By Region
19.3.3. Medical Equipment Market, 2016, By Country
19.2.4. Medical Equipment Market, 2012 - 2020, Historic And Forecast, By Country
19.2.5. Global Medical Equipment Market, Growth And Market Share Comparison, By Segment
19.2.6. Global Medical Equipment Market, Growth And Market Share Comparison, By Country And Segment
19.3. Global Medical Equipment Market Comparison With Macro Economic Factors
19.3.1. Medical Equipment Market Size, Percentage Of GDP, Global
19.3.2. Per Capita Average Medical Equipment Expenditure, Global
19.4. Medical Equipment Market Comparison With Macro Economic Factors Across Countries
19.4.1. Medical Equipment Market Size, Percentage Of GDP, By Country
19.4.2. Per Capita Average Medical Equipment Expenditure, By Country
19.5. Key Mergers And Acquisitions In The Medical Equipment Market
20. Healthcare Industry Financial Margins
21. Appendix
21.1. NAICS Definitions Of Industry Covered In This Report
21.2. Abbreviations
21.3. Currencies
21.4. Research Inquiries
21.5. The Business Research Company
21.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report